新聞集錦
NEW

采風智匯「腰椎」骨鬆AI軟體 再獲TFDA許可；《Lancet》子刊：AZ氣喘藥比黃金治療標準類固醇更有效
醫療科技
NEW

北醫衍生新創神瑞 首個「心肺」雙篩AI平台獲TFDA認證

生技醫藥
NEW

順藥腦中風新藥LT3001 中國臨床二期安全性達標、具療效潛力

GBI International
GBIHighlights

Leadgene Biomedical, Inc.'s LEADGENE® IS ELISA Kit has been approved by Taiwan's FDA...

2024-02-28/GlobalBio & Investment
#TFDAApprovalExcitingnews!LeadgeneBiomedical,Inc.'sLEADGENE®IndoxylSulfate(IS)ELISAKit,aCE-markedprotein-boundtoxindiagnosiskit,hasbeenapprovedbyTaiwan'sFDAasaClassIIIinvitrodiagnosticdevi...
GBI International
GBIHighlights

Nine biopharma companies have announced record-high revenues for January

2024-02-28/GlobalBio & Investment
#BiotechGrowthExcitingnewsfromthe#biopharmasector!Ninebiopharmacompanieshaveannouncedrecord-highrevenuesforJanuary,indicatingaprosperousstarttotheyear.Amongthem,AnxoPharmaceuticalTaiwanCo.Ltd(6677.TWO...
GBI International
GBIHighlights

FDA approves Onivyde® as a first-line therapy for metastatic pancreatic adenocarcinoma

2024-02-28/GlobalBio & Investment
**#FDAApproval**ExcitingnewsforPharmaEngineInc(4162.TWO)!FDAapproves#Onivyde®asafirst-linetherapyformetastaticpancreaticadenocarcinoma,markingapotentialnewstandardofcare.PharmaEngine'scollabor...
GBI International
GBIHighlights

The potential of next-generation microbiome therapy in clinical applications (8th AMC)

2024-02-28/GlobalBio & Investment
*#MicrobiomeTherapy**Canthegutmicrobiotarevolutionizecancertreatment?Insightsfromthe8thAsiaMicrobiomeConference(#AMC),heldbyIBCAcademiaSinica,NationalTaiwanUniversityHospital,and圖爾思生物科技BIOTOOLSCO.,LTD...
GBI International
GBIHighlights

Chang Gung Medical Foundation teams up with Gilead Sciences to accelerate early-stage clinical trial

2024-02-28/GlobalBio & Investment
**#ClinicalTrials**ChangGungMedicalFoundationteamsupwithGileadSciencestoaccelerateearly-stageclinicaltrials,focusingon#oncology.Thecollaborationaimstoadvanceclinicaltrialsintumorresearch,preclinicalco...
GBI International
GBIHighlights

GBI Spotlight: Dr. Han-Chung Wu

2024-02-28/GlobalBio & Investment
#GBISpotlight:Dr.Han-ChungWu(吳漢忠)MeetDr.Han-ChungWu,themanbehindthedevelopmentofprecisiontherapythroughinnovativephagedisplaytechnology.AstheDirectorofBioTrecatNBRP,AcademiaSinica,heisawell-knownfigur...
GBI International
GBIHighlights

Meet David Lee, the visionary founder and CEO of Singular Wings Medical

2024-02-28/GlobalBio & Investment
**#Meet#StartupCEOs**MeetDavidLee(李維中),thevisionaryfounderandCEOofSingularWingsMedical.Fromtheelectronicsindustrytoentrepreneurship,hemerges#healthcarewith#electronics,craftinginnovativesolutionsforme...
GBI International
GBIHighlights

Merck's Keytruda Leads 2023 Sales!

2024-02-28/GlobalBio & Investment
**Merck'sKeytrudaLeads2023Sales!**Merck'sKeytrudaemergesasthetop-sellingdrugof2023,amassinganimpressive$25billioninsales.MerckCFOCarolineLitchfieldattributesKeytruda'ssurgein2023torecentap...
GBI International
GBIHighlights

TBMC partners with U.S. firm National Resilience, Inc. for advanced bioprocessing

2024-02-28/GlobalBio & Investment
**ExcitingNews!TaiwanBio-ManufacturingCorporation(#TBMC),the‘biotechTSMC,’partnerswithU.S.firmNationalResilience,Inc.foradvancedbioprocessing.ChairmanMichelChu(瞿志豪)outlinesaglobalapproachf...
GBI International
GBIHighlights

AnBogen Therapeutics hits a milestone: completes USD 12.5M Series A funding round!

2024-02-28/GlobalBio & Investment
**AnBogenTherapeuticshitsamilestone:completesUSD12.5MSeriesAfundinground!**InastrategicmoveledbyCDIBCapitalInternationalCorporation,AnBogenTherapeuticsproudlyannouncesthesuccessfulclosureofitsSeriesAf...
GBI International
GBIHighlights

Revolutionizing Antibiotics: Xtraordinary Discovery by NCHU team!

2024-02-28/GlobalBio & Investment
*RevolutionizingAntibiotics:XtraordinaryDiscoverybyNationalChungHsingUniversity(#NCHU)team!**NCHUresearchersmadeagroundbreakingdiscoveryinantibioticdevelopment.Theyfoundanucleotidesignalingmoleculetha...
GBI International
GBIHighlights

EirGenix, Inc. and Sartorius delves into critical aspects such as sterile filtration

2024-02-28/GlobalBio & Investment
**MasteringQualityAssurance!**SartoriusTaiwanelevatesproductqualitythroughrobustfiltrationsystemtesting.RZLin,aSartoriusTechSpecialist,underscoresthecrucialroleofQualityRiskManagement(#QRM)inmaintaini...

TOP
  • Global Bio and Investment Monthly
  • 讀者服務電話：+886 2 2726 1065時間：週一 ~ 週五 09:00 ~ 18:00
  • 服務信箱：[email protected]
  • 地址：110臺北市信義區信義路六段29號2樓之一, Taiwan

我們的服務